Search
News
Preclinical Study Shows Targeted Drug Strengthens the Power of CAR T-Cell Therapy in Two Pediatric Leukemias
… Therapy in Two Pediatric Leukemias Roswell Park’s Dr. Lisa Niswander presents research results at American Society of … KMT2A-rearranged acute lymphoblastic leukemia (ALL). Lisa Niswander, MD, PhD , Assistant Professor of Oncology in the … toxicities and improve long-term remission,” says Dr. Niswander. “Our preclinical studies take a two-pronged …
News
Hyundai Hope On Wheels Awards $100,000 to Roswell Park to Fund Infant Leukemia Immunotherapy Research
… that get us closer to ending childhood cancer Dr. Lisa Niswander receives $100,000 from Hyundai Hope on Wheels … cancer. The Hyundai Impact Award was presented to Lisa Niswander, MD, PhD , at Roswell Park on Wednesday for … for pediatric acute lymphoblastic leukemia (ALL). Dr. Niswander, a Buffalo native, works in the Department of …
Clinical Trial
(AALL2131) An International Pilot Study of Chemotherapy and Tyrosine Kinase Inhibitors with Blinatumomab in Patients with Newly-Diagnosed Philadelphia Chromosome-Positive or ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
… Chromosome-Like B-cell Acute Lymphoblastic Leukemia III Niswander, Lisa M This pilot trial assesses the effect of the …
News
Roswell Park Experts to Showcase Groundbreaking Hematology Research at 66th ASH Annual Meeting
… is senior author. On Saturday, Dec. 7, at 4:45 p.m., Lisa Niswander, MD, PhD , will present abstract 370, Gliteritinib … is senior author. On Saturday, Dec. 7, at 4:45 p.m., Lisa Niswander, MD, PhD , will present abstract 370, Gliteritinib …